Back
Philip Morris International Vs. Monopar Therapeutics Industry Stock Comparison
Buy
60
PM
Philip Morris International
Last Price:
$155.02
Seasonality Move:
2.1%
Sell
43
MNPR
Monopar Therapeutics
Last Price:
$41.00
Seasonality Move:
-14.17%
Buy
60
Philip Morris International (PM)
is a Buy
Is Philip Morris International a Buy, Sell or Hold?
-
The current Philip Morris International [PM] share price is $154.33. The Score for PM is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
PM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $38.10. The Score for MNPR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PM Stock Price Chart
What is Philip Morris International's stock price today?
-
The Philip Morris International share price today is $154.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PM is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $38.10Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.3 | Buy |
Relative Strength Index (14 RSI): | 59.53 | Buy |
Chaikin Money Flow: | 2947207 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (150.86 - 155.38) | Buy |
Bollinger Bands (100): | (122.3 - 147.22) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 53.92 | Buy |
Chaikin Money Flow: | 16104 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.92 - 40.18) | Buy |
Bollinger Bands (100): | (19.15 - 39.21) | Buy |
PM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 153.24 | Buy |
20-day SMA: | 153.3 | Buy |
50-day SMA: | 142.31 | Buy |
200-day SMA: | 124.78 | Buy |
8-day EMA: | 152.87 | Buy |
20-day EMA: | 151.71 | Buy |
50-day EMA: | 144.96 | Buy |
200-day EMA: | 126.91 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.22 | Sell |
20-day SMA: | 33.78 | Buy |
50-day SMA: | 37.25 | Buy |
200-day SMA: | 16.69 | Buy |
8-day EMA: | 37.42 | Buy |
20-day EMA: | 36.3 | Buy |
50-day EMA: | 34.68 | Buy |
200-day EMA: | 21.35 | Buy |
Philip Morris International Earnings Growth & PM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.25 per share, an increase this year of $0.63 per share, and an increase next year of $0.72 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Philip Morris International Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |